Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Shu Chen Wei; Ting An Chang; Te Hsin Chao; Jinn Shiun Chen; Jen Wei Chou; Yenn Hwei Chou; Chiao Hsiung Chuang; Wen Hung Hsu; Tien Yu Huang; Tzu Chi Hsu; Chun Chi Lin; Hung Hsin Lin; Jen Kou Lin; Wei Chen Lin; Yen Hsuan NI; Ming Jium Shieh; I Lun Shih; Chia Tung Shun; Yuk Ming Tsang; Cheng Yi Wang; Horng Yuan Wang; Meng Tzu Weng; Deng Chyang WU; Wen Chieh WU; Hsu Heng Yen; Jau Min Wong

Return

Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Author: Shu Chen WEI ¹ ; Ting An CHANG ; Te Hsin CHAO ; Jinn Shiun CHEN ; Jen Wei CHOU ; Yenn Hwei CHOU ; Chiao Hsiung CHUANG ; Wen Hung HSU ; Tien Yu HUANG ; Tzu Chi HSU ; Chun Chi LIN ; Hung Hsin LIN ; Jen Kou LIN ; Wei Chen LIN ; Yen Hsuan NI ; Ming Jium SHIEH ; I Lun SHIH ; Chia Tung SHUN ; Yuk Ming TSANG ; Cheng Yi WANG ; Horng Yuan WANG ; Meng Tzu WENG ; Deng Chyang WU ; Wen Chieh WU ; Hsu Heng YEN ; Jau Min WONG
Author Information

1. Department of Internal Medicine, National Taiwan University Hospital, National Taiwan University College of Medicine, Taipei, Taiwan. jmwong@ntu.edu.tw
Publication Type:Review
Keywords: Taiwan; Crohn disease; Inflammatory bowel diseases; Disease management; Consensus statements
MeSH: Adrenal Cortex Hormones; Asian Continental Ancestry Group; Biological Therapy; Consensus*; Crohn Disease*; Diagnosis; Disease Management; Expert Testimony; Gastrointestinal Tract; Hepatitis B virus; Humans; Incidence; Inflammatory Bowel Diseases*; Magnetic Resonance Imaging; Prevalence; Quality of Life; Taiwan*; Tuberculosis
From:Intestinal Research 2017;15(3):285-310
CountryRepublic of Korea
Language:English
Abstract: Crohn's disease (CD) is a chronic relapsing and remitting inflammatory disease of the gastrointestinal tract. CD is rare in Taiwan and other Asian countries, but its prevalence and incidence have been steadily increasing. A steering committee was established by the Taiwan Society of Inflammatory Bowel Disease to formulate statements on the diagnosis and management of CD taking into account currently available evidence and the expert opinion of the committee. Thorough clinical, endoscopic, and histological assessments are required for accurate diagnosis of CD. Computed tomography and magnetic resonance imaging are complementary to endoscopic evaluation for disease staging and detecting complications. The goals of CD management are to induce and maintain remission, reduce the risk of complications, and improve quality of life. Corticosteroids are the mainstay for inducing re-mission. Immunomodulating and biologic therapies should be used to maintain remission. Patients should be evaluated for hepatitis B virus and tuberculosis infection prior to treatment and receive regular surveillance for cancer. These consensus statements are based on current local evidence with consideration of factors, and could be serve as concise and practical guidelines for supporting clinicians in the management of patients with CD in Taiwan.